Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics and Effects of DDH-LSD vs LSD in Healthy Volunteers
NCT07309471Phase 1Recruiting
- Sponsor
- University Hospital Basel
- Start
- Mar 2026
- Primary completion
- Jul 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of DDH-LSD (3 arms), sponsored by University Hospital Basel. Primary endpoints: Effective DDH-LSD dose at 13 hours, Duration of action at 13 hours and 1 more. Started Mar 2026; status: recruiting.
02
Drugs
DDH-LSD
Beyond the preview
Go deeper on NCT07309471.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07309471.